{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-142093","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.504287+00:00","generated_at":"2026-05-19T04:13:02.987926+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Plus Therapeutics cuts Series B warrant shares from 1.26B to 35.5M; cancels Series A warrants","bullets":["Cancelled all Series A warrants exercisable for up to 280M shares of common stock.","Series B warrants amended to reduce total shares issuable from ~1.26B to ~35.5M; cashless exercise ratio cut from 3:1 to 1:1.","Investors agreed to return ~12.2M Private Placement Shares and Pre-Funded Warrants in exchange for 115% repayment from future capital raises.","Registration Rights Agreement terminated; restrictions on subsequent equity sales waived."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-142093","json":"https://secwatch.observer/filing/0001193125-25-142093.json","markdown":"https://secwatch.observer/filing/0001193125-25-142093.md","text":"https://secwatch.observer/filing/0001193125-25-142093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312525142093/0001193125-25-142093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312525142093/d942989d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:13:02.987926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}